London, Feb 7, 2026, 08:26 GMT — Trading isn’t underway; markets remain closed.
- Unilever finished flat at 5,250p, falling behind broader gains across UK stocks.
- Unilever has put out 4.2 million fresh shares related to its employee schemes, a regulatory filing showed.
- Unilever’s Q4 and full-year results are up next, scheduled for Feb. 12. The company has investor events planned the following week.
Unilever PLC ended Friday unchanged at 5,250 pence, sticking within a 5,210p to 5,298p band through the session. Shares wrapped the week up about 6%. Markets in London have shut for the weekend. Unilever’s results hit early next week.
The FTSE 100 notched a 0.6% gain by Friday’s close, propped up by heavyweight banks and hints from the Bank of England that rate cuts could come if inflation stays in check. Unilever—long considered a safe haven—has traders focused squarely on earnings now, with less attention on its correlation to the wider market.
Unilever has scheduled its Q4 and full-year 2025 earnings release for Feb. 12, and the CAGNY Conference is on the books for Feb. 17, according to the company’s investor calendar. On the same page, analyst consensus points to 3.9% underlying sales growth in Q4, 3.5% for the full year, an underlying operating margin holding at 20.0%, and underlying EPS coming in at 3.05 euros.
Unilever rolled out another regulatory notice this week, this time with a routine flavor. The company said it had issued 4.2 million new ordinary shares—now listed on the London Stock Exchange—to cover employee share plan vesting. That lifts the total number of ordinary shares admitted to 2,185,205,247.
Investors are zeroing in on whether higher volumes are really driving the numbers. Consumer staples can boost growth with price hikes, but when demand looks shaky and promotions start popping up again, markets typically react negatively.
Margins are up for inspection. Investors are on alert for clues about input costs, and they’re also watching whether spending on brands is creeping higher—competition isn’t letting up in staples, from personal care to home care and packaged foods.
What peers are up to matters for the read-across, reporting this day or not. European staples, along with global packaged goods, keep their “defensive” label as the tape moves. Still, earnings season tends to flip the story in a hurry.
But there’s a catch. Should volumes underwhelm, margin guidance turn shaky, or signs emerge that price-fueled growth is losing steam, the week’s earlier gains could unravel in a hurry. The shares are already hovering near the top of their recent range, adding to the pressure.
Unilever’s U.S. ADR ended Friday’s session in New York up 0.8%, settling at $72.12.
Unilever’s Feb. 12 earnings could set the tone next week, especially as markets tune in for any clues—or silences—on where 2026 demand and profit goals stand. Then on Feb. 17, all eyes shift to CAGNY, where investors will be parsing updates on strategy and the state of Unilever’s categories.
